Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Randomized phase II trials and prostate-specific antigen endpoints in prostate cancer: much ado about nothing? J Clin Oncol 2005 Nov 01;23(31):8124-5; author reply 8125-6

Date

11/01/2005

Pubmed ID

16258115

DOI

10.1200/JCO.2005.03.2458

Scopus ID

2-s2.0-32944469067 (requires institutional sign-in at Scopus site)   2 Citations

Author List

Stadler WM, Michaelis LC, Ratain MJ

Author

Laura Michaelis MD Chief, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Clinical Trials, Phase II as Topic
Humans
Male
Neoplasms, Hormone-Dependent
Prostate-Specific Antigen
Prostatic Neoplasms
Randomized Controlled Trials as Topic
Treatment Outcome